Sanford Burnham Prebys is uncovering the origins of disease
to maximize their impact on human health
needed to solve medicine's most challenging problems
meaningful clinical benefit and growing further discovery
The Latest News
-
Education
New internship program ignites a SPARK
For the first time, Sanford Burnham Prebys hosted high school interns from the SPARK program, an initiative by the California Institute for Regenerative Medicine (CIRM) that provides biomedical research opportunities for underrepresented groups throughout California. -
Genetic Disorders and Aging
Timothy Huang awarded $2.8M to study well-known gene linked to Alzheimer’s disease
The project aims to uncover a potential cause of Alzheimer’s brain pathology -
Assistant Professor Jianhua Zhao, Ph.D., has been awarded a unique and competitive NIH grant to study the molecular machinery of protein recycling and discover new targets for cancer therapies.
-
This year's Preuss internship program was hosted by the Institue's NCI-designated Cancer Center.
-
Sanford Burnham Prebys recently hosted a celebration to honor the anniversary of the Institute’s founding. More than 200 scientists, students and staff gathered to commemorate 46 years of world-class biomedical research.
-
Immunotherapy has revolutionized cancer treatment, but it doesn’t work on many childhood brain tumors. Researchers from Sanford Burnham Prebys are working to change that.
-
Sanford Burnham Prebys Cancer researchers Ani Deshpande, Brooke Emerling, and Charles Spruck have all been promoted from assistant to associate professor.
-
The four-year, $2.3 million project could accelerate the development of new therapies for a range of cancers, particularly metastatic breast cancer. It also offers an answer to a longstanding mystery in cancer metabolism.
-
Scientists and staff from across the Institute gathered to celebrate LGBTQ+ Pride at Sanford Burnham Prebys by attending a Pride flag raising ceremony
-
The Fellowship is awarded every two years to a Sanford Burnahm Prebys postdoc leading the charge in their field.
-
In the News
From zebra fish to bacteria, Diabetes Research Connection celebrates a decade funding novel ideas
San Diego group has provided more than $2 million to early-career scientists across the country conducting maverick research on Type 1 diabetes, including the lab run by developmental geneticist Duc Dong at Sanford Burnham Prebys. -
Children's Health
Alagille syndrome: a promising therapy races towards clinical trials
Recent breakthroughs from Professor Duc Dong and his team bring great promise to the Alagille community and are also cause for the wider rare disease community to pay attention.
Living History
NCI-Designated Cancer Center
Earning the NCI designation in 1981 — just five years after its modest start in downtown La Jolla — our Cancer Center truly is "the miracle on Torrey Pines Mesa."

Next Generation
Svasti Haricharan and Brooke Emerling featured in GEN
Svasti Haricharan, Ph.D. and Brooke Emerling, Ph.D. are leveraging cellular signaling to potentially change the way we treat breast cancer.

Living History
Along the road to discovery
It was in 1979 when Eva Engvall asked Erkki Ruoslahti a question that would change their lives forever: "Wouldn't it be great to work in San Diego?"

Next Generation
Graduate student Katja Birker's research doesn't miss a beat
"There is no magic wand to cure congenital heart conditions–we have to do the research."

Calendar
Seminar
Symposium
Gia Voeltz, Ph.D.
University of Colorado
Event
Seminar
Seminar
Seminar
Our Partners in Discovery
We can't do it alone
Our annual Rare Disease Day symposium strengthens the global network of families, physicians and researchers to better understand and fight rare diseases in children.

Our Partners in Discovery
Getting to the finish line faster
Thanks to the philanthropic vision of Stuart and Karen Tanz, a unique collaboration seeks new treatments for diseases such as Alzheimer’s, dementia and Parkinson’s.

Our Partners in Discovery
New hope for autoimmune disease
Our partnership with Lilly—centered around a high degree of interaction—has already produced an immune therapy now in clinical trial.

Our Partners in Discovery
A master class in collaboration
Meet T. Denny Sanford, Conrad Prebys and Malin Burnham: three people who know we're stronger when we work together.
